This inventor holds 3 USPTO granted patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Florian Puenner: Innovator in Heterocyclic Compounds
Introduction
Florian Puenner is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic potential for various diseases.
Latest Patents
Florian Puenner holds a patent for a heterocyclic compound that exhibits glucosylceramide synthase inhibitory action. This invention is expected to be beneficial in the prophylaxis or treatment of lysosomal storage diseases, such as Gaucher's disease and Fabry's disease, as well as neurodegenerative diseases like Parkinson's disease. The compound is represented by a specific formula, and its potential applications are promising for improving patient outcomes in these serious conditions. He has 1 patent to his name.
Career Highlights
Florian Puenner is currently employed at Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work focuses on innovative solutions that address unmet medical needs, particularly in the areas of rare diseases and neurodegenerative disorders.
Collaborations
Florian collaborates with talented colleagues, including Yuta Tanaka and Fumiaki Kikuchi, who contribute to the research and development efforts at Takeda Pharmaceutical Company Limited.
Conclusion
Florian Puenner's work in developing heterocyclic compounds showcases his commitment to advancing medical science and improving treatment options for patients with complex diseases. His contributions are vital in the ongoing quest for effective therapies.